Organization · Family Office
DOLIAM
DOLIAM is a French family-owned private joint stock company that invests in and supports high-tech, MedTech, and DeepTech startups. Established in 1991, it operates in France and the United States, providing strategic guidance and operational support to its portfolio companies.
Overview
What DOLIAM does
What DOLIAM is
DOLIAM is a French family-owned private joint stock company that invests in and supports high-tech, MedTech, and DeepTech startups. Established in 1991, it operates in France and the United States, providing strategic guidance and operational support to its portfolio companies.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Family Office
- Founded
- Founded in 1991
- Approximate age
- About 35 years
- Structured capabilities
- Funder
- Last reviewed
- March 28, 2026
Official channels
Find DOLIAM elsewhere
Open the official website or a supported primary organization account.
Capability profile
DOLIAM as a funder
Investment thesis
DOLIAM focuses on investing in and supporting startups and innovative companies in the MedTech and DeepTech sectors, aiming to accelerate growth and foster cooperation between public and private institutions.
Focus narrative
DOLIAM invests in and supports startups and innovative companies primarily in the MedTech and DeepTech sectors. Their mission is to accelerate growth from strategic orientation to operational execution, addressing challenges in industrialization and supply chain access for startups. The organization aims to foster cooperation between public and private academic institutions in research, education, and innovation.
Value beyond capital
DOLIAM adds value to its portfolio companies by providing strategic guidance, operational support, and facilitating access to industrialization and supply chain resources, enhancing their growth potential.
Portfolio and track record
Portfolio context
Notable companies within the DOLIAM group include Vermon, which specializes in customized ultrasound transducers; Moduleus, focusing on high-performance ultrasound imaging solutions; Cairdac, known for the first self-sustainable leadless pacemaker; Olythe, innovating in gas analysis; Vitruvens, providing energy solutions for medical implants; PCB-CONCEPT, an expert in printed circuit board design; Fineheart, developing a hybrid device for heart failure; Iconeus, offering ultrasound neurofunctional imaging systems; and Injectpower, creating microbatteries for implantable medical devices.
Common questions
What to know about DOLIAM
Upseed classifies DOLIAM under the Family Office organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 28, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.